Why UnitedHealth Group’s Impressive ROE Is Not Translating Into Growth
UnitedHealth Group’s stock has declined by 11% in the past three months, despite strong financial metrics. The company’s Return on Equity (ROE) is 15%, significantly higher than the industry average of 11%, indicating efficient profit generation. UnitedHealth’s net income growth averages only
